196
Views
2
CrossRef citations to date
0
Altmetric
Obstetrics and Gynaecology: Original article

Comfort, ease of use and practicality of the pen injector for follitropin α for assisted reproduction: an observational post-marketing study in Egypt

, , , , , & show all
Pages 1429-1434 | Accepted 17 Jul 2013, Published online: 04 Sep 2013

References

  • National Institute for Health and Clinical Excellence. Clinical Guideline 11. Fertility: assessment and treatment for people with fertility problems. Available at: http://www.nice.org.uk/guidance/CG11/NICEGuidance [Last accessed January 2013]
  • Gonal-F®: European Summary of Product Characteristics, Merck Serono. Available at: http://www.medicines.org.uk/EMC/ [Last accessed January 2013]
  • Gonal-F® Pen: US Prescribing Information. Available at: http://www.emdserono.com/en/therapies/fertility/gonal_f/gonal_f.html [Last accessed January 2013]
  • Christen M, Schertz JC, Arriagada P, et al. The redesigned follitropin α pen injector for infertility treatment. Expert Opin Drug Deliv 2011;8:833-9
  • Somkuti SG, Schertz JC, Moore M, et al. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women. Curr Med Res Opin 2006;22:1981-96
  • Aghssa MM, Azargoon A, Ramezanzadeh F, et al. A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles. Fertil Steril 2008;90:1043-8
  • Welcker JT, Nawroth F, Bilger W. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study. Reprod Biol Endocrinol 2010;8:111
  • Hovatta O, McVeigh E, Lass A, et al. A large Northern European observational study of follitropin alpha filled-by-mass pre-filled pen. Reprod Biomed Online 2009;18:502-8
  • Porter R, Kissel C, Saunders H, et al. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens. Curr Med Res Opin 2008;24:727-35
  • Weiss N. Gonadotrophin products: empowering patients to choose the product that meets their needs. Reprod Biomed Online 2007;15:31-7
  • Schertz JC, Saunders H, Hecker C, et al. The redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testing. Expert Opin Drug Deliv 2011;8:1111-20
  • Rama Raju GA, Suryanarayana K, Jaya Prakash G, et al. Comparison of follitropin-beta administered by a pen device with conventional syringe in an ART programme – a retrospective study. J Clin Pharm Ther 2008;33:401-7
  • Christianson MS, Barker MA, Schouweiler C, et al. A retrospective comparison of clinical outcomes and satisfaction using reconstituted recombinant gonadotropins (rFSH) or cartridge rFSH with a pen device in donor oocyte cycles. Curr Med Res Opin 2007;23:865-70
  • Pearson TL. Practical aspects of insulin pen devices. J Diabetes Sci Technol 2010;4:522-31
  • Brunton S. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens. Diabetes Technol Ther 2008;10:247-56
  • Serour GI. Islamic perspectives in human reproduction. Reprod Biomed Online 2008;17(Suppl 3):34-8
  • Serour GI. Medical and socio-cultural aspects of infertility in the Middle East. ESHRE Monographs 2008;1:34-41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.